1. Bernstein JE, Korman NJ, Bickers DR, et al. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989;21:265-70.
2. Sklar SH, Blue WT, Alexander EJ, et al. Herpes zoster. The treatment and prevention of neuralgia with adenosine monophosphate. JAMA 1985;253:1427-30.
3. Sklar SH, Wigand JS. Herpes zoster. Br J Dermatol 1981;104:351-2.
4. Baba M, Shigeta S. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antivir Res 1987;7:99-107.
5. Schiller F. Herpes zoster: review, with preliminary report on new method for treatment of postherpetic neuralgia. J Am Geriatr Soc 1954;2:726-35.
6. Heyblon R. Vitamin B12 in herpes zoster. JAMA 1951;146:1338 (abstract).
7. Ayres S Jr, Mihan R. Post-herpes zoster neuralgia: response to vitamin E therapy. Arch Dermatol 1973;108:855-66.
8. Ayres S Jr, Mihan R. Post-herpes zoster neuralgia: response to vitamin E therapy. Arch Dermatol 1975;111:396.
9. Coghlan CJ. Herpes zoster treated by acupuncture. Cent Afr J Med 1992;38:466-7.
10. Lewith GT, Field J, Machin D. Acupuncture compared with placebo in post-herpetic pain. Pain 1983;17:361-8.
11. Shenefelt PD. Hypnosis in dermatology. Arch Dermatol 2000;136:393-9.
12. Irwin M, Costlow C, Williams H, et al. Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis 1998;178 (Suppl 1):S104-8.
13. Engberg IB, Grondahl GB, Thibom K. Patients' experiences of herpes zoster and postherpetic neuralgia. J Adv Nurs 1995;21:427-33.
14. Schmader K, George LK, Burchett BM, Pieper CF. Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis 1998;178 (Suppl 1):S67-70.
15. Schmader K, Studenski S, MacMillan J, et al. Are stressful life events risk factors for herpes zoster? J Am Geriatr Soc 1990;38:1188-94.
16. Gupta MA, Gupta AK. Herpes zoster in the medically healthy child and covert severe child abuse. Cutis 2000;66:221-3.